Antibiotic-Cilicaine-Antibiotics
From Tech Solutions Documentation
The Hopkins team was specifically hunting for immune system control agents within the Johns Hopkins zithromax chicken pox Drug Library, a collection assembled over the past seven years by Liu and colleagues of more than 3,000 drugs in pharmacies or being tested in phase II clinical trials. "We never expected that an old antibiotic would hit this target that has been implicated azithromycin treatment of boils boil in multiple sclerosis, psoriasis and type 1 diabetes," says Johns Hopkins pharmacologist Jun O.
Teaching An Old Drug New Tricks
Leprosy medicine holds promise as therapy for autoimmune diseasesA century-old drug that failed in its original intent to treat genital herpes images tuberculosis but has worked azithromycin well as an antileprosy
drug has a tremendous effect on human immune cells that are heavily involved in both the initiation and execution of an effective immune response."
More specifically, Liu's team sought drugs that stop the molecular signaling pathway that leads from the surface of an immune system cell to the cell's interior, azithromycin australia where the signal turns on genes important in activating the immune response, Liu says. "Until now, clofazimine's presumed target was not human cells,
but bacteria," says Liu, professor of pharmacology and molecular science, Johns Hopkins University School of Medicine. One of the key steps involved in turning on the immune response is the prolonged accumulation of calcium inside of immune cells, Liu explains.
an immune cell, setting the signaling event in motion, they noticed that lots of calcium flushed into the cell and lingered there. In autoimmune diseases, a person's own white blood cells, meant antibiotics to fight infection or disease, are misguided to target and attack the body's own cells, damaging or destroying them. Next, by buying antibiotics systematically studying the multistep signaling process, the researchers pinpointed clofazimine's azythromycin molecular target, a protein "pore" called ion channel Kv1.3, which plays an essential role in the complicated signaling process. Liu "People have been working for years and spending tens of millions of dollars on developing a drug to inhibit a specific molecular target involved in these diseases, and here, we have a safe, known drug that hits that target," known as the Kv1.3 potassium channel. The Johns Hopkins scientists say they were surprised to discover that clofazimine interferes with a molecular pathway important in orchestrating the human body's immune response. The finding about clofazimine, a synthetic compound made in the 1890s, is reported in Public Library of Science (PLoS One) by Johns Hopkins researchers, who uncovered the drug's latest potential during an ongoing and exhaustive screening of FDA-approved drugs designed to identify new uses for them.